Advertisement
The corresponding presentation slides are available for download in theinvestor relations section of QIAGEN's Web site at www.QIAGEN.com/goto/050808.
Advertisement
Contact: Andreas Marathovouniotis, Russo Partners, (212) 845-4235
QIAGEN N.V., a Netherlands holding company, is the leading provider ofsample and assay technologies. Sample technologies are used to isolate andprocess DNA, RNA and proteins from biological samples such as blood or tissue.Assay technologies are used to make such isolated biomolecules visible. QIAGENhas developed and markets more than 500 consumable products as well asautomated solutions for such consumables. The company provides its products tomolecular diagnostics laboratories, academic researchers, pharmaceutical andbiotechnology companies, and applied testing customers for purposes such asforensics, animal or food testing and pharmaceutical process control. QIAGEN'sassay technologies include what is considered to be the broadest panel ofmolecular diagnostic tests available worldwide. This panel includes the onlyFDA-approved test for human papillomavirus (HPV), the primary cause ofcervical cancer.
QIAGEN employs more than 2,700 people in over 30 locations worldwide.Further information about QIAGEN can be found at www.qiagen.com.
(Minimum Requirements to listen to broadcast: The RealPlayer software,downloadable free from http://www.real.com/products/player/index.html, or TheWindows Media Player, downloadable free from www.microsoft.com and at least a14.4Kbps connection to the Internet. If you experience problems listening tothe broadcast, send an email to [email protected].)What: Webcast of QIAGEN's second quarter 2008 financial results call When: 9:30 a.m. EDT on August 5 Where: The Webcast is accessible at www.QIAGEN.com/goto/050808. How: Log on to the Web at the address above.
SOURCE QIAGEN N.V.